Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

Journal of Clinical Investigation

Volumn 119, Issue 12, 2009, Pages 3573-3585

  Eyerich, Stefanie ^a   Eyerich, Kilian ^b   Pennino, Davide ^b   Carbone, Teresa ^b   Nasorri, Francesca ^b   Pallotta, Sabatino ^b   Cianfarani, Francesca ^b   Odorisio, Teresa ^b   Traidl Hoffmann, Claudia ^c   Behrendt, Heidrun ^c   Durham, Stephen R ^a   Schmidt Weber, Carsten B ^a   Cavani, Andrea ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT; ANGIOGENESIS; ARTICLE; CYTOKINE RELEASE; EPIDERMIS; FIBROSIS; GENE EXPRESSION; HELPER CELL; HUMAN; IMMUNITY; IN VITRO STUDY; INNATE IMMUNITY; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; TH22 CELL; WOUND HEALING;

ADULT; CLONE CELLS; DERMATITIS; EPIDERMIS; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKINS; KERATINOCYTES; PSORIASIS; RECEPTORS, CCR10; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 72849131815     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40202     Document Type: Article

References (48)

1. Burgler, S., et al. 2009. Differentiation and functional analysis of human T(H)17 cells. J. Allergy Clin. Immunol. 123:588-595; e581-e587.
2. Eyerich, K., et al. 2009. IL-17 in atopic eczema: linking allergen-specific adaptive and microbialtriggered innate immune response. J. Allergy Clin. Immunol. 123:59-66; e54.
3. Aujla, S.J., et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-281. (Pubitemid 351347908)
4. Schmidt-Weber, C.B., Akdis, M., and Akdis, C.A. 2007. TH17 cells in the big picture of immunology. J. Allergy Clin. Immunol. 120:247-254.
5. Liang, S.C., et al. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203:2271-2279.
6. Kreymborg, K., et al. 2007. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179:8098-8104.
7. Cupedo, T., et al. 2009. Human fetal lymphoid tissue- inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat. Immunol. 10:66-74.
8. Nograles, K.E., et al. 2009. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing T(H)17 T cells. J. Allergy Clin. Immunol. 123:1244.e2-1252.e2.
9. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., and Sallusto, F. 2009. Production of interleukin 22 but not interleukin 17 by a subset of human skinhoming memory T cells. Nat. Immunol. 10:857-863.
10. Trifari, S., Kaplan, C.D., Tran, E.H., Crellin, N.K., and Spits, H. 2009. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 10:864-871.
11. Wolk, K., et al. 2005. Is there an interaction between interleukin-10 and interleukin-22? Genes Immun. 6:8-18. (Pubitemid 40260128)
12. Lejeune, D., et al. 2002. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 277:33676-33682. (Pubitemid 35056175)
13. Wolk, K., et al. 2004. IL-22 increases the innate immunity of tissues. Immunity. 21:241-254. (Pubitemid 39094053)
14. Boniface, K., et al. 2005. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174:3695-3702. (Pubitemid 40354080)
15. Andoh, A., et al. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 129:969-984. (Pubitemid 41242688)
16. Zenewicz, L.A., et al. 2007. Interleukin-22 but not interleukin- 17 provides protection to hepatocytes during acute liver inflammation. Immunity. 27:647-659.
17. Pan, H., Hong, F., Radaeva, S., and Gao, B. 2004. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell. Mol. Immunol. 1:43-49.
18. Ma, H.L., et al. 2008. IL-22 is required for Th17 cellmediated pathology in a mouse model of psoriasislike skin inflammation. J. Clin. Invest. 118:597-607.
19. Boniface, K., et al. 2007. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin. Exp. Immunol. 150:407-415. (Pubitemid 350098734)
20. Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., and Tokura, Y. 2008. Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128:2625-2630.
21. Ricciardi, L., et al. 2009. Increased serum levels of IL-22 in patients with nickel contact dermatitis. Contact Dermatitis. 60:57-58.
22. Larsen, J.M., Bonefeld, C.M., Poulsen, S.S., Geisler, C., and Skov, L. 2009. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. J. Allergy Clin. Immunol. 123:486-492.
23. Lee, Y.K., et al. 2009. Late developmental plasticity in the T helper 17 lineage. Immunity. 30:92-107.
24. Siegmund, K., et al. 2009. Unique phenotype of human tonsillar and in vitro-induced FOXP3+ CD8+ T cells. J. Immunol. 182:2124-2130.
25. Arican, O., Aral, M., Sasmaz, S., and Ciragil, P. 2005. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005:273-279. (Pubitemid 41577417)
26. Ouaked, N., et al. 2009. Regulation of the foxp3 gene by the Th1 cytokines: the role of IL-27- induced STAT1. J. Immunol. 182:1041-1049.
27. Satoh-Takayama, N., et al. 2008. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 29:958-970.
28. Malmberg, K.J., and Ljunggren, H.G. 2009. Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes. Nat. Immunol. 10:11-12.
29. Cella, M., et al. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 457:722-725.
30. Annunziato, F., et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204:1849-1861.
31. Ivanov, I.I., et al. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126:1121-1133.
32. Almus, F.E., Rao, L.V., Pendurthi, U.R., Quattrochi, L., and Rapaport, S.I. 1991. Mechanism for diminished tissue factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin. Blood. 77:1256-1262.
33. Winkles, J.A., et al. 1987. Human vascular smooth muscle cells both express and respond to heparinbinding growth factor I (endothelial cell growth factor). Proc. Natl. Acad. Sci. U. S. A. 84:7124-7128. (Pubitemid 18017321)
34. Reuss, B., Dono, R., and Unsicker, K. 2003. Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants. J. Neurosci. 23:6404-6412. (Pubitemid 36909865)
35. Ota, Y., et al. 2002. Fibroblast growth factor 5 inhibits hair growth by blocking dermal papilla cell activation. Biochem. Biophys. Res. Commun. 290:169-176. (Pubitemid 34694479)
36. Cho, Y.M., et al. 2003. Hair-cycle-dependent expression of parathyroid hormone-related protein and its type I receptor: evidence for regulation at the anagen to catagen transition. J. Invest. Dermatol. 120:715-727.
37. Kovacs, D., et al. 2005. Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis. Exp. Dermatol. 14:130-137. (Pubitemid 40277580)
38. Sharpe, R.J., Arndt, K.A., Bauer, S.I., and Maione, T.E. 1989. Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes. Arch. Dermatol. 125:1359-1362. (Pubitemid 19252850)
39. Varga, J., and Abraham, D. 2007. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117:557-567. (Pubitemid 46348510)
40. Hwang, J., et al. 2005. Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine. 30:254-263. (Pubitemid 40775844)
41. Hwang, J., et al. 2004. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett. 570:47-51.
42. Honorati, M.C., Cattini, L., and Facchini, A. 2004. IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis Cartilage. 12:683-691. (Pubitemid 39172743)
43. Albanesi, C., et al. 2000. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J. Invest. Dermatol. 115:81-87. (Pubitemid 30470196)
44. Wolk, K., et al. 2006. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36:1309-1323.
45. Li, W., et al. 2009. The serine protease marapsin is expressed in stratified squamous epithelia and is up-regulated in the hyperproliferative epidermis of psoriasis and regenerating wounds. J. Biol. Chem. 284:218-228.
46. Hanifin, J.M., and Rajka, G. 1980. Diagnostic features of atopic dermatitis. Acta. Derm. Venereol. (Stockh.). 92(Suppl.):44-47.
47. Andersen, K.E., et al. 1987. Contact dermatitis. A review. Contact Dermatitis. 16:55-78.
48. Cavani, A., et al. 2000. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J. Invest. Dermatol. 114:295-302. (Pubitemid 30417764)